• News
  • SAN DIEGO
  • BioTech

Trovagene to begin collaboration with Dana-Farber Cancer Institute

San Diego-based Trovagene Inc. (Nasdaq: TROV) has entered into a clinical collaboration with Dana-Farber Cancer Institute to investigate the utility of quantitative urine-based mutation detection, and the ability to monitor tumor mutation burden and treatment response over time in metastatic melanoma patients.

To continue reading, subscribe now
or
log in to your account
User Response
0 UserComments

Trovagene Inc.

Company Website

11055 Flintkote Ave.
San Diego, CA 92121

Company Trade Data

Stock Symbol Close
Change
Chg %Chg
Volume
52-Week
High Low
TROV
4.24
  -0.21  
- 4.72%
31,805,000
7.91
2.97

Trovagene Inc. Executive(s):

Antonius Schuh

  • Chief Executive Officer

Stephen Zaniboni

  • Chief Financial Officer
Subscribe Today!